Toutes les informations sur:

Nom	Glenmark Pharmaceuticals Europe R&D Limited
Adresse	Laxmi House 2-B Draycott Avenue Kenton Harrow HA3 0BU
VAT ID (Numéro de TVA)	no VAT ID available
Société Numéro de Registre	06420547 Show on Companies House
Statut de Société	Dissolved
Fondé	7 novembre 2007
Accounts	SMALL last accounts made up to 31 mars 2020
Activité (Code NAF)	72110 - Recherche-développement en biotechnologie
Noms Précédents	Glenmark Pharmaceuticals Europe Limited Newincco 778 Limited
KYC Check KYC checks will cover 240 countries and 40 languages for both corporates and individuals: PEP - Any individual that is considered a Politically Exposed Person, from Head of State to Members of Parliament, Members of the Board of State Owned Enterprises or Ambassadors and individuals representing their countries interests abroad. Sanction - Any individual or entity that is (or was) subject to sanctions by either the European Union, the United Nations, the United States Office of Foreign Assets Control and State Department and Her Majesty’s Treasury in the United Kingdom. Financial Regulator - Any individual or entity that has been fined or in some other way subject to action by any financial regulatory body. Law Enforcement - Any individual or entity that has been named in official documentation from Law Enforcement bodies such as the Police or any other agency such as Interpol or the FBI. Also those individuals and entities cited in Court and legal documents of that nature. Adverse Media - Any individual or entity that has been reported in global newspapers, news sites or other media as being involved in financial crime. Other country specific datasets	KYC / PEP / AML request

This data is incorrect?
Source: Company Register: Companies House (companieshouse.gov.uk)

go to our Search Engine

Quick access

Persons with Significant Control
Officers
Similar VAT Registered Companies

Persons with Significant Control (3)

Source: Companies House

Pinto, Cherylann Status: Active Notified: 06/04/2016 Date of Birth: 01/1967 Nature of Control

Ownership of shares 25 to 50 percent as trust

Saldanha, Blanche Elizabeth Status: Active Notified: 06/04/2016 Date of Birth: 07/1940 Nature of Control

Ownership of shares 25 to 50 percent as trust

Saldanha, Glenn Status: Active Notified: 06/04/2016 Date of Birth: 11/1969 Nature of Control

Significant influence or control

Officers (1)

Source: Companies House

Bourne, Oliver Henry Kenton, Harrow, Middlesex, United Kingdom Status: Active Notified: 20/08/2015 Date of Birth: 06/1980 Occupation: None Role: Director Country of Residence: United Kingdom Nationality: British

Toutes les informations sur:

Glenmark Pharmaceuticals Europe R&D Limited

Quick access

Persons with Significant Control (3)

Officers (1)